GI
SLS icon

GAMMA Investing’s SELLAS Life Sciences SLS Stock Holding History

GAMMA Investing’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$26.9K Buy
2,186
+1,630
+293% +$20.4K ﹤0.01% 2765
2026
Q2 		$8.21K Sell
556
-259
-32% -$1.79K ﹤0.01% 3292
2026
Q1 		$3.45K Buy
815
+443
+119% +$1.98K ﹤0.01% 3504
2025
Q4 		$1.4K Buy
+372
New +$723 ﹤0.01% 3703

Other funds holding SLS

EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
EM
ELCO Management New York $213M AUM 25.23% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM
FD
Financial Designs Claremont, California $194M AUM 10.52% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing's SLS Position: Q3 2026 in Review

GAMMA Investing increased its SELLAS Life Sciences (SLS) stake by 293% in Q3 2026, buying an estimated $20.4K and bringing the position to 2,186 shares worth $26.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2765.

GAMMA Investing first reported a position in SLS in Q4 2025 and has held it in 4 quarters since. 12 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • GAMMA Investing held 2,186 shares of SELLAS Life Sciences worth $26.9K as of Q3 2026.
  • GAMMA Investing bought 1,630 SELLAS Life Sciences shares in Q3 2026, an estimated $20.4K.
  • SELLAS Life Sciences made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2765 holding.
  • GAMMA Investing first reported a position in SELLAS Life Sciences in Q4 2025 and has held it in 4 quarters since.
  • 12 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.